AVROBIO

-$0.06 (-0.82%) As of 7:57 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVROBIO and other ETFs, options, and stocks.

About AVRO

Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen.

CEO

Geoff MacKay

Employees

—

Headquarters

Cambridge, Massachusetts

Founded

2015

AVRO Key Statistics

Market Cap

378.31M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

218.35K

High Today

$7.42

Low Today

$7.11

Open Price

$7.21

Volume

109.42K

52 Week High

$20.07

52 Week Low

$7.11

Analyst Ratings

80%

of 10 ratings

Buy

80%

Hold

20%

Sell

AVRO Earnings

-$1.01

-$0.67

-$0.34

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 12, Pre-Market